FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2808495927> ?p ?o ?g. }

• W2808495927 endingPage "1950" @default.
• W2808495927 startingPage "1941" @default.
• W2808495927 abstract "Abstract Ovarian cancer is the leading cause of gynecologic cancer-related deaths and novel therapeutic strategies are required. Programmed cell death 1 and programmed cell death ligand 1 (PD-L1), which are key mediators of host immune tolerance, are associated with ovarian cancer progression. Recent evidence indicates the importance of IFNγ-induced PD-L1 for immune tolerance in ovarian cancer. This study aimed to reveal the therapeutic potential of suppressor of cytokine signaling 1 (SOCS-1), an endogenous inhibitor of the Janus kinase (JAK)–STAT signaling pathway, for the treatment of ovarian cancer. IHC assessment revealed that patients with ovarian cancer with high intratumoral STAT1 activation exhibited poor prognosis compared with patients with low STAT1 activation (P &lt; 0.05). Stimulation of OVISE, OVTOKO, OV2944-HM-1 (HM-1), and CT26 cell lines with IFNγ induced STAT1 phosphorylation and PD-L1 expression. Adenovirus-mediated SOCS-1 gene delivery (AdSOCS-1) in HM-1 and CT26 cells in vitro potently inhibited IFNγ-induced STAT1 phosphorylation and PD-L1 upregulation, similar to the addition of JAK inhibitor I, but failed to inhibit their proliferation. Notably, intratumoral injection of AdSOCS-1, but not AdLacZ, significantly inhibited the tumor growth of HM-1 and CT26 cells subcutaneously transplanted in immunocompetent syngeneic mice. AdSOCS-1 reduced PD-L1 expression on tumors and restored the activation of tumor-infiltrating CD8+ T cells. Moreover, the antitumor effect of AdSOCS-1 was significantly attenuated by PD-L1 Fc-fusion protein administration in vivo, suggesting that the effect of AdSOCS-1 is mainly attributable to enhancement of tumor immunity. This study highlights the potential clinical utility of SOCS-1 as an immune checkpoint inhibitor. Mol Cancer Ther; 17(9); 1941–50. ©2018 AACR." @default.
• W2808495927 created "2018-06-21" @default.
• W2808495927 creator A5002638004 @default.
• W2808495927 creator A5004882510 @default.
• W2808495927 creator A5009314886 @default.
• W2808495927 creator A5013910008 @default.
• W2808495927 creator A5018600874 @default.
• W2808495927 creator A5020771892 @default.
• W2808495927 creator A5021463605 @default.
• W2808495927 creator A5055405608 @default.
• W2808495927 creator A5058902589 @default.
• W2808495927 creator A5065154218 @default.
• W2808495927 creator A5070119035 @default.
• W2808495927 creator A5071731375 @default.
• W2808495927 creator A5072463831 @default.
• W2808495927 date "2018-09-01" @default.
• W2808495927 modified "2023-10-16" @default.
• W2808495927 title "Intratumoral Delivery of an Adenoviral Vector Carrying the <i>SOCS-1</i> Gene Enhances T-Cell–Mediated Antitumor Immunity By Suppressing PD-L1" @default.
• W2808495927 cites W1548640328 @default.
• W2808495927 cites W1558521455 @default.
• W2808495927 cites W1815125329 @default.
• W2808495927 cites W1946263079 @default.
• W2808495927 cites W1974988922 @default.
• W2808495927 cites W1975929837 @default.
• W2808495927 cites W1979842508 @default.
• W2808495927 cites W1980927217 @default.
• W2808495927 cites W1998060649 @default.
• W2808495927 cites W1999601075 @default.
• W2808495927 cites W2006122393 @default.
• W2808495927 cites W2013178046 @default.
• W2808495927 cites W2022120278 @default.
• W2808495927 cites W2039427849 @default.
• W2808495927 cites W2054787206 @default.
• W2808495927 cites W2056635301 @default.
• W2808495927 cites W2066671159 @default.
• W2808495927 cites W2076151893 @default.
• W2808495927 cites W2078844752 @default.
• W2808495927 cites W2080810010 @default.
• W2808495927 cites W2089889294 @default.
• W2808495927 cites W2092921437 @default.
• W2808495927 cites W2103383530 @default.
• W2808495927 cites W2115351357 @default.
• W2808495927 cites W2115372673 @default.
• W2808495927 cites W2117926449 @default.
• W2808495927 cites W2119596771 @default.
• W2808495927 cites W2121743767 @default.
• W2808495927 cites W2129088290 @default.
• W2808495927 cites W2136313650 @default.
• W2808495927 cites W2141155424 @default.
• W2808495927 cites W2143772132 @default.
• W2808495927 cites W2147622445 @default.
• W2808495927 cites W2149360266 @default.
• W2808495927 cites W2153414586 @default.
• W2808495927 cites W2162013743 @default.
• W2808495927 cites W2165948908 @default.
• W2808495927 cites W2174256729 @default.
• W2808495927 cites W2191601131 @default.
• W2808495927 cites W2273988729 @default.
• W2808495927 cites W2340636398 @default.
• W2808495927 cites W2589697864 @default.
• W2808495927 cites W259732519 @default.
• W2808495927 cites W2746363893 @default.
• W2808495927 doi "https://doi.org/10.1158/1535-7163.mct-17-0822" @default.
• W2808495927 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29891489" @default.
• W2808495927 hasPublicationYear "2018" @default.
• W2808495927 type Work @default.
• W2808495927 sameAs 2808495927 @default.
• W2808495927 citedByCount "7" @default.
• W2808495927 countsByYear W28084959272019 @default.
• W2808495927 countsByYear W28084959272020 @default.
• W2808495927 countsByYear W28084959272021 @default.
• W2808495927 countsByYear W28084959272022 @default.
• W2808495927 crossrefType "journal-article" @default.
• W2808495927 hasAuthorship W2808495927A5002638004 @default.
• W2808495927 hasAuthorship W2808495927A5004882510 @default.
• W2808495927 hasAuthorship W2808495927A5009314886 @default.
• W2808495927 hasAuthorship W2808495927A5013910008 @default.
• W2808495927 hasAuthorship W2808495927A5018600874 @default.
• W2808495927 hasAuthorship W2808495927A5020771892 @default.
• W2808495927 hasAuthorship W2808495927A5021463605 @default.
• W2808495927 hasAuthorship W2808495927A5055405608 @default.
• W2808495927 hasAuthorship W2808495927A5058902589 @default.
• W2808495927 hasAuthorship W2808495927A5065154218 @default.
• W2808495927 hasAuthorship W2808495927A5070119035 @default.
• W2808495927 hasAuthorship W2808495927A5071731375 @default.
• W2808495927 hasAuthorship W2808495927A5072463831 @default.
• W2808495927 hasConcept C112392421 @default.
• W2808495927 hasConcept C121608353 @default.
• W2808495927 hasConcept C126322002 @default.
• W2808495927 hasConcept C167672396 @default.
• W2808495927 hasConcept C203014093 @default.
• W2808495927 hasConcept C2776178377 @default.
• W2808495927 hasConcept C2777003663 @default.
• W2808495927 hasConcept C2778690821 @default.
• W2808495927 hasConcept C2780427987 @default.
• W2808495927 hasConcept C502942594 @default.
• W2808495927 hasConcept C71924100 @default.
• W2808495927 hasConcept C86803240 @default.

• next